Invention Grant
- Patent Title: Methods for treating osteogenesis imperfecta
-
Application No.: US14772708Application Date: 2014-03-20
-
Publication No.: US09598486B2Publication Date: 2017-03-21
- Inventor: Brendan Lee , Kuber T. Sampath
- Applicant: Genzyme Corporation , Baylor College of Medicine
- Applicant Address: US MA Cambridge US TX Houston
- Assignee: GENZYME CORPORATION,BAYLOR COLLEGE OF MEDICINE
- Current Assignee: GENZYME CORPORATION,BAYLOR COLLEGE OF MEDICINE
- Current Assignee Address: US MA Cambridge US TX Houston
- Agency: Lathrop & Gage LLP
- Agent James H. Velema, Esq.
- International Application: PCT/US2014/031279 WO 20140320
- International Announcement: WO2014/153435 WO 20140925
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K33/42 ; C07K16/22 ; A61K39/00
Abstract:
The present invention provides methods for treating and improving the symptoms of osteogenesis imperfecta (OI) in a subject by administering to the subject a therapeutically effective amount of a binding agent that binds to transforming growth factor beta (TGFβ).
Public/Granted literature
- US20160031979A1 METHODS FOR TREATING OSTEOGENESIS IMPERFECTA Public/Granted day:2016-02-04
Information query
